ClinicalTrials.Veeva

Menu

Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training

G

German Cancer Research Center

Status and phase

Completed
Phase 2

Conditions

Weight Loss
Hodgkin Disease
Bronchial Carcinoma
Gastrointestinal Neoplasms
Non-Hodgkin Lymphoma

Treatments

Drug: N-acetylcysteine

Study type

Interventional

Funder types

Other

Identifiers

NCT00196885
whilde157/2003

Details and patient eligibility

About

The purpose of the study is to tests the hypothesis, that N-acetylcysteine (a thiol-antioxidant)improves the exercise training effect on cancer patients that experience weight loss (cachexia) as assessed by muscle mass and function as well as histomorphology.

Sex

All

Ages

20 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • gastrointestinal or bronchial cancer
  • weight loss of 10% within 6 months
  • sufficient mobility

Exclusion criteria

  • severe pain, steroid therapy, severe internal, muscular, neurological, psychiatric disease, N-acetylcysteine allergy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems